Actinium Pharma Balance Sheet - Annual (NYSEMKT:ATNM)

Add to My Stocks
$0.73 $0 (0%) ATNM stock closing price Sep 19, 2018 (Closing)

The fundamental analysis of this company requires a thorough look at Actinium Pharma balance sheet. All three financial statements should be used to measure the financial performance of the company, and should form a part of the Actinium Pharma stock analysis. Good annual results indicate a company's strong financial performance. Its important to check all financial statements including the balance sheet. Apart from analyzing Actinium Pharma revenue Actinium Pharma operating cash flow, one needs to check balance sheet items like cash, fixed assets and debt. The Actinium Pharma balance sheet for 2017 shows cash on hand of $17.39M. The company has a debt to equity ratio of .

View latest 10 year balance sheet data to check Actinium Pharma financial performance.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011201020092008
Cash17.39M20.55M25.67M6.7M5.53M5.61M----
Marketable Securities----------
Receivables----------
Inventory----------
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets-1.83M--------
Total Current Assets
17.83M22.39M26.48M7.4M5.75M5.78M----
Property Plant & Equipment----------
Accumulated Depreciation----------
Net Property Plant & Equipment
----------
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges----------
Intangibles----------
Deposits & Other Assets----------
Total Assets
18.33M22.52M26.58M7.56M5.76M5.78M----
Notes Payable----------
Accounts Payable4.65M4.21M1.49M2.49M------
Current Portion Long-Term Debt----------
Current Portion Capital Leases----------
Accrued Expenses----------
Income Taxes Payable----------
Other Current Liabilities--2.84M6.7M6.7M3.57M----
Total Current Liabilities
4.66M4.52M4.61M9.49M7.32M4.64M----
Mortgages----------
Deferred Taxes/Income----------
Convertible Debt----------
Long-Term Debt----------
Non-Current Capital Leases----------
Other Long-Term Liabilities----------
Total Liabilities
4.66M4.52M4.61M9.49M7.32M4.64M----
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus176.74M154.5M134.16M89.25M64.93M56.67M----
Retained Earnings-163.15M-136.55M-112.23M-91.2M-66.51M-55.74M-0.25M-0.27M-0.27M-0.24M
Treasury Stock----------
Other Liabilities----------
Shareholders Equity13.67M18M21.97M-1.92M-1.55M1.14M-0.08M-0.09M-0.09M-0.07M
Total Liabilities & Shareholders Equity18.33M22.52M26.58M7.56M5.76M5.78M----
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Most investors just check the Actinium Pharma stock price, and Actinium Pharma historical stock prices before investing. While share price is an important factor, one should also look at financials and valuation metrics like the Actinium Pharma PE ratio chart. Below is a brief explanation of common balance sheet terms:

  • Assets: An asset is a resource that a corporation like Actinium Pharma owns and has monetary significance. ATNM assets decreased from $22.52M in 2016 to $18.33M in 2017. Assets can be of two types: fixed assets like real estate, plant and machinery; and current assets which includes cash, accounts receivable etc. Tech stocks typically don't have too many assets.
  • Liabilities include short term loans and long term loans availed by the company to fund its business operations. ATNM stock had total liabilities of $4.66M for the year 2017.

Actinium Pharma Balance Sheet - Key Ratios